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IOPAbstract The rationale of the present work is to formulate and evaluate metoprolol tartrate (MT),
which is a beta-1 selective adrenergic blocking agent in a new ocular gel delivery system; this is our
way and method to increase its contact to the cornea, giving a longer time of drug contact to the eye
and slow possible release from the preparation. Metoprolol tartrate is chosen as a candidate for gel
formulation because although it has been available for a few years as ophthalmic solutions, it has
not been marketed as an ocular gel yet. Two polymers; Carbopol 934 and Pluronic F127 (PF127)
were used in two different concentrations in this study. Metoprolol tartrate was used in two con-
centrations, 0.5% and 1% (w/w). All formulations were exposed to visual examinations, pH mea-
surement, in vitro release, rheological study and differential scanning calorimetry (DSC). Results
showed that all formulations were clear, showed pH within the acceptable range suitable to be
administered in the eye, and exhibited pseudoplastic ﬂow behavior. DSC results concluded that,
MT was compatible with different polymers used. In vitro release results showed that the release
rate of metoprolol tartrate from gel preparations decreased as an inverse function of polymer con-
centration, and the release rate of the drug increased as the initial concentration increased. Intra-
ocular pressure (IOP) measurements of rabbit’s eye treated with 1% (w/w) metoprolol tartrate in
gel formulations with different concentrations of the polymer were determined. Carbopol 934 gel
formulations showed that this polymer extended the duration of pressure reducing effect of MT
556 A. E. s. F. Abou el Ela, M.M.E. Khatibto more than 5hr when compared with Pluronic F127 gel formulations. The area above the curve
(AAC), maximum response, time of maximum response (tmax), and the duration of the drug action
were also calculated.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).O
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Figure 1 Chemical structure of metoprolol tartrate (Luch, 1983).1. Introduction
It is often assumed that drugs administered topically to the eye
are rapidly absorbed and are available at a desired site in the
globe of the eye to exert their therapeutic effect. Indeed, this
is generally not the case. Were this true we would not see drug
products containing as much as 5–10% of such systemically
active drugs as atropine, homatropine, and pilocarpine. When
a quantity of a topical ophthalmic dosage form is applied to
the eye, generally to the lower cul-de-sac, several factors imme-
diately begin to affect the availability of the drug contained in
that quantity of the dosage forms (Habib and Attia, 1984).
Although many methods of instilling drugs to the eye have
been experimented with the use of drops has emerged and still
remains the major method of administration for the topical
route. Poor bioavailability of drugs from ocular dosage forms
is mainly due to tear production, transient residence time, and
impermeability of corneal epithelium (Kaur and Kanwar,
2002). Due to these physiological and anatomical constraints
only a small amount of drug, effectively 1% or less of the in-
stilled dose, is absorbed oculary. So far, many attempts have
been made to improve ocular bioavailability by extending drug
residence time in the conjunctival sac and improve drug pene-
tration across the cornea, the major pathway of drug entry into
the internal eye (Kaur and Kanwar, 2002).
Several ways of prolonging the presence of drugs in precor-
neal area consist of increasing the viscosity of the dosage form
by adding a number of viscosity imparting agents such as
water soluble or insoluble, natural, synthetic, and semisyn-
thetic polymers (El-Kamel, 2002). Many studies reported that
the aqueous-base gels appear to offer several advantages over
the other traditional ophthalmic dosage forms, either in terms
of improved ocular bioavailability or enhanced therapeutic re-
sponse (Zaki et al., 2011). Many of the ophthalmic gels inves-
tigated to date have been formulated with either Carbopols or
Poloxamers. Poloxamers are a class of gel forming polymers
that have been evaluated as semisolid vehicles for the ophthal-
mic use (Ma et al., 2008; Gratieri et al., 2010).
Poloxamer 407 (Pluronic F127) possesses several properties
which appear to make it particularly suitable for use in the for-
mulation of ophthalmic dosage forms, including its low toxic-
ity, mucomimetic properties, and optical clarity (Waring and
Harris, 1979). Carbopol is a polyacrylic acid polymer, which
shows a sol-to-gel transition in aqueous solution as the pH is
raised above its pka of about 5.5 and it is widely used in
ophthalmology to enhance precorneal retention to the eye
(Deshmukh and Gattani, 2013). Moreover, Carbopol exhibits
excellent mucoadhesive properties when compared with other
polymers.
Metoprolol tartrate, MT (Fig. 1) is a selective beta-1 block-
ing agent and because of its ability to lower the elevated intra-
ocular pressure (IOP), it is used clinically to treat patients with
ocular hypertension or glaucoma, primarily of the open angle
type (Luch, 1983).Treatment with metoprolol tartrate as 0.5%,1%, 2%, 3%, 4%, 5%, and 8% eye drops was clinically stud-
ied. It was found that, the IOP was signiﬁcantly lowered by the
drug in all patients throughout the study but a short-lasting
reduction in IOP was obtained with 0.5% eye drops. In addi-
tion, the concentrations over 1% were less well tolerated (Alm
and Wickstro¨m, 1980; Krieglstein, 1981). The Metoprolol eye
drops had no effect on the diameter of the pupil of the eye,
blood pressure or resting pulse and moreover, the reduction
in intraocular pressure and duration of action showed no dim-
inution (Bucheli et al., 1980).
The aim of this work is the formulation and evaluation of a
new gel ocular delivery system of metoprolol tartrate using
Carbopol 934 and Pluronic F127. The rheological behavior
of the studied formulations was carried out. The formulation
variables that could affect the release rate and absorption of
the drug in the topical formulations, such as the polymer type,
concentration of gelling agent, and the initial drug concentra-
tion in the formulations were studied. In addition, the in vivo
performance of gel formulations of MT was assessed on the
basis of the inﬂuence of the drug on the intra-ocular pressure
of rabbit’s eye, and the duration of the pressure reducing ef-
fect. The effect of the drug on the pupil diameter of the eye
was also visually examined.
2. Materials and methods
2.1. Materials
Metoprolol tartrate was kindly donated by (Sid. Co., for Phar-
maceutical and Chemical Industry, Egypt). Carbopol 934 (CP
934) was purchased from (Goodrich Chemical Company, OH,
USA), Pluronic F127 (PF127) was obtained from (BASF
Corp., Wyan-dotte, MI). All other chemicals were of analytical
grade.
2.2. Methods
2.2.1. Preparation of metoprolol tartrate gels
The gel formulations containing two different concentrations
of the drug (0.5% and 1% w/w) were prepared according to
the polymer used and the composition is shown in Table 1.
Table 1 Composition of metoprolol tartrate gel formulations % (w/w).
Ingredient F1 F2 F3 F4 F5 F6 F7 F8
Metoprolol tartrate 0.5 1 0.5 1 0.5 1 0.5 1
Carbopol 934P 1 1 2 2 – – – –
Pluronic F127 – – – – 25 25 30 30
Benzalkonium chloride 0.005 0.005 0.005 0.005 0.005 0.005 0.005 0.005
Puriﬁed water to 100 100 100 100 100 100 100 100
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Pluronic F127 gels containing 25% and 30% (w/w) were pre-
pared by the cold method (Schmolka, 1972). The weighed
amount of the polymer was slowly added to the water with
gentle mixing. The mixture was left in a refrigerator at 4 C
overnight to complete dissolution of the polymer. After the
formation of a clear viscous solution, a solution of the drug
(0.5% and 1% w/w) in a sterile water was added to the poly-
mer solution and mixed gently using a magnetic stirrer. Drops
of a sodium hydroxide solution (0.1 N) were added to adjust
the pH of the prepared solutions to 6.8. Benzalkonium chlo-
ride (0.005% w/w) as a preservative and sodium chloride to ad-
just the tonicity were added. The concentration of an
isotonicity agent, sodium chloride that rendered the formula-
tions isotonic with the eye ﬂuid was calculated by the sodium
chloride equivalent method (Martin, 1993). The solutions were
left at room temperature until a clear gel was formed. Gel for-
mulations were prepared one day prior to the use and plain gel
was also prepared as a blank for each experiment.
2.2.3. Preparation of Carbopol gels
Carbopol 934 gels (1%, 2% w/w) were prepared according to
the previously reported method (French et al., 1995). Carbopol
was added to the water portion wise with a gentle mixing.
After complete addition of the polymer and mixing, the drug
solution (0.5% and 1% w/w) was added. Benzalkonium chlo-
ride (0.005% w/w) as a preservative and sodium chloride to ad-
just the tonicity were added. The gel was spontaneously
formed by the addition of a triethanolamine.
2.2.4. Physical examination
The prepared gel formulations were inspected visually for their
appearance (clarity). The pH values of 1% aqueous solu-
tions of the prepared gels were measured by a pH meter (pH
meMettler-Toledo GmbH, Switzerland).
2.2.5. Differential scanning calorimetry (DSC)
DSC studies were carried out for MT, each of the used poly-
mer and the corresponding physical mixture (1:1) separately
in order to determine any incompatibility between the ingredi-
ents. Samples of about 5 mg were accurately weighed and
encapsulated into ﬂat-bottomed aluminum pans with
crimped-on lids (DSC-50, shimadzu Co., Japan). The scanning
speed of 10 C/min from 30 C to 200 C was used in the pres-
ence of nitrogen at a ﬂow rate of 20 ml/min (Karthikeyan
et al., 2010).
2.2.6. Rheological studies
The determination of the viscosity of prepared gel formula-
tions was carried out at 34 ± 0.5 C using a cone and plate vis-
cometer with spindle 52 (Brookﬁeld Engineering Laboratories,model HADV-II, Middleboro, MA) and connected to a ther-
mostatically controlled circulating water bath (Polyscience,
model 9101, Niles, IL). About 0.5 g of the formula to be tested
was applied to the plate and left for equilibrium. The shear rate
was increased from 100 to 500 s1 for Carbopol gels and from
10 to 100 s1 for Pluronic F127 gels with120 s between each 2
successive speeds. The viscosity was determined from the ﬂow
curve obtained at different values of the shear rate. All mea-
surements were made in duplicate.
2.2.7. In vitro release studies
In vitro release of metoprolol tartrate from different gel for-
mulations was carried out in 100 ml of phosphate buffered
solution of pH 6.8 at 37 ± 0.5 C at 50 rpm using the dialysis
method. A semipermeable standard cellophane membrane
(molecular cut of 12,000, Sigma Chem. Co., USA) was
stretched over the open end of a dialysis cell (2.5 cm diameter
and 10 cm in length). One gram of different gel formulations
was placed in the dialysis cell, which was suspended so that
the membrane was just below the surface of the buffered solu-
tion. Samples of 5 ml each were withdrawn from the beaker
content at different time intervals, and measured using a UV
spectrophotometer (Shimadzu, UV-150–02, Japan) at 275 nm
against a blank similarly treated (Ramana et al., 2007). The re-
moved samples were replaced by equal volumes of the phos-
phate buffered solution. Each of the in vitro release tests was
repeated three times.
2.2.8. Kinetic analysis of the release data
In vitro release data were analyzed using the equation pro-
posed by Korsmeyer (Abou el Ela et al., 2013):
Mt=M1 ¼ ktn
where Mt/M1 is the fractional amount of the drug released
from the formulation at time t, k is the release rate constant
and n is the diffusion exponent that characterizes the type of
the release mechanism during the release process. The values
of n and k were estimated by the linear regression of
log(Mt/M1) versus log t.
2.2.9. In vivo study design and data treatment
Three adult male albino rabbits of weight ranging from 1.5 to
2.0 kg were used in this study. During experiments the test ani-
mals were kept in individual cages with free access to food and
water. One week at least elapsed between tests in the same
rabbit. It was established that this period of time ensured the
absence of any carry-over effect or contribution to the ob-
served pharmacological response. Isotonic xylocaine solution
(2% v/v) was dropped into rabbits’ eyes to anaesthetize the
cornea. It was proved experimentally that xylocaine had no
effect on the pupil diameter or IOP of the eye. Ophthalmic
gel formulations were applied into the right eye, while the left
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placed in the supine position, the upper eyelid was slightly
raised and the lower eyelid was gently pulled away, thus allow-
ing the drug to be in contact with the eye ball taking care not
to exert pressure on the globe with the investigating ﬁngers. In
all cases topical doses of 0.1 g each were instilled in the lower
conjunctival sac of the eye. The eyelids were held closed for
30–45 s following instillation. After administration of the test
formulation, the IOP of both eyes, starting with the right
eye, was measured every one hr for 5 h using a Schiotz tonom-
eter (Riester, Germany). The pupil diameters were also mea-
sured visually using Haab’s pupillometer. At least three
individual successive measurements were made at each time
point and the mean was calculated. Four parameters have been
utilized to assess the in vivo performance of MT, which are the
area above the intraocular pressure–time curve (AAC), the
maximum response (MR) to the drug in terms of IOP, the time
of the maximum response (tmax) and the duration of the drug
action (DA).
2.2.10. Statistical analysis
The results were presented as mean ± SD. The in vivo data of
the effect of MT on the IOP of rabbits’ eyes were compared
using t-test, and ANOVA test.3. Results and discussion
3.1. Physical examination
The prepared MT gel formulations were clear and the pH val-
ues of all the prepared formulations ranged from 6.84 to 6.92,50.00 100.00
Tem
-30.00
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10.00
20.00
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Figure 2 DSC thermograms showing compatibilitywhich are considered acceptable to avoid the risk of irritation
upon application to the eye.
3.2. Compatibility study between MT and polymers
The compatibility of MT with the different polymers used such
as Carbopol 934 and PF127 was studied using DSC. The ther-
mal curves of MT, the polymer, and the MT-polymer physical
mixtures (1:1) are shown in Fig. 2. DSC curve showed an endo-
thermic peak at 125.15 C for metoprolol tartrate and about the
same melting endotherm peak was observed for the other drug–
physical mixtures (125.27 C and 123.42 C for MT–Carbopol
and MT–Pluronic, respectively). Moreover, the enthalpy of
the endotherm was also calculated and it was 107.34, 34.38
and 34.65 (J/g) for MT, MT-Carbopol and MT–Pluronic,
respectively. It is clear that, MT alone has a high enthalpy value
while its value decreased after the addition to the molted poly-
mer. There is a non signiﬁcant change in the thaw melting point
after the mixing of MT with the polymers. The thaw melting
points were 119.46, 111.1 and 114.88 C forMT,MT–Carbopol
andMT–Pluronic, respectively. This result conﬁrms that there is
no mutual interaction between the drug and the polymers.3.3. Rheological studies
Table 2 and Figs. 3–5 show the ﬂow behavior of all MT gel for-
mulations. It is clear that, all the prepared gel formulations
exhibited non Newtonian pseudoplastic ﬂow behavior (shear
thinning systems) at 34 ± 0.5 C. As the shear rate is in-
creased, the normally molecular structure of the gelling
material is caused to align its long axes in the direction of a150.00 200.00
p [C]
Metoprolol
Pluronic F1
27
Carbopol934
Meto-Plur 1:1
Meto-Carbo 1:1
of metoprolol tartrate with the used polymers.
  
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
18
100 200 250 300 350 400 450 500
Carbopol 1%
Carbopol 2%
Shear rate (1/s)
Vi
sc
os
ity
 (P
as
)
Figure 3 Viscosity-shear rate bar chart of 0.5%MT gels contain-
ing various concentrations of Carbopol (n= 2, mean ± SD).
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Figure 4 Viscosity-shear rate bar chart of 1% MT gels contain-
ing various concentrations of Carbopol (n= 2, mean ± SD).
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Figure 5 Effect of concentration and type of polymers on the
viscosity of MT gels (shear rate = 100 s1).
Table 2 Rheological measurements of Pluronic F127 gel formulations containing MT at 34 ± 0.5 C (n= 2, mean ± SD).
Viscosity (Pas)
shear rate (1/s) 25% PF127 30% PF127
0.5% MT 1% MT 0.5% MT 1% MT
10 7.96 ± 0.16 8.72 ± 0.81 12.28 ± 1.36 15.09 ± 2.40
20 4.52 ± 0.07 5.01 ± 0.58 5.80 ± 0.78 7.84 ± 1.51
30 3.09 ± 0.14 3.58 ± 0.04 4.41 ± 0.57 5.56 ± 0.92
40 2.44 ± 0.26 2.99 ± 0.16 4.16 ± 0.52 4.81 ± 0.41
50 2.13 ± 0.40 2.88 ± 0.30 3.97 ± 0.02 4.29 ± 0.28
60 2.01 ± 0.57 2.66 ± 0.37 3.38 ± 0.08 3.79 ± 0.21
70 1.87 ± 0.64 2.42 ± 0.49 3.17 ± 0.15 3.23 ± 0.18
100 1.78 ± 0.68 2.19 ± 0.16 2.37 ± 0.20 2.75 ± 0.19
Long acting metoprolol tartrate ophthalmic gels 559ﬂow which in turns reduces the internal resistance of the mate-
rial and hence decreases its viscosity. Fig. 3 shows the relation-
ship between the viscosity and the shear rate of 1% and 2%
Carbopol gels containing the same concentration of MT
(0.5% w/w). It is clear that, by increasing the Carbopol con-
centration, the viscosity value was slightly increased. The same
results were observed using higher MT concentration (1% w/
w) as shown in Fig. 4. The viscosity of 2% Carbopolgels con-
taining 1% drug is slightly higher than that containing 0.5%
drug, this is at all shear rates used with the exception at the
shear rate of 100 s1, where the viscosity is slightly lower
(Fig. 5).Table 2 illustrates the effect of using PluronicF127 in
the two different concentrations (25% and 30% w/w) on the
viscosity of gel formulations. A pseudoplastic ﬂow also wasobtained and moreover, the gels containing 30% Pluronic
F127 exhibited a higher viscosity than that of 25%. This is
in agreement with the previous results obtained (El-kamel,
2002). This pseudoplastic behavior of PF127 formulations
has also been observed previously (Mansour et al., 2008). It
is obvious that by increasing the concentration of PF127 from
25 to 30% w/w for F6, F8 respectively, the viscosity is in-
creased. This is in agreement with the previous results obtained
by Jain et al.,1998; Mayol et al., 2008 concluded that a gel is
more entangled at higher PF127 concentrations. The recorded
viscosity data of the various MT gels at the shear rate of 100
s1 are presented in Fig. 5, which shows that the Carbopol
based gels (F1–F4) exhibited signiﬁcantly (p< 0.05) greater
viscosities than Pluronic F127 gels (F5–F8). It was concluded
that the increase in the viscosity by increasing the concentra-
tions of both the drug and the polymers used was non-signiﬁ-
cant. It was reported that the ocular shear rate is a very
important parameter and ranges from 0.03 s1 to 28,500 s1
so the viscoelastic ﬂuids with a viscosity that is high under
low shear rate and low under the high shear rate conditions
are often preferred (Zaki et al., 2011).
3.4. In vitro release of MT from different formulations
3.4.1. Effect of polymer concentration on drug release
In vitro release of MT from different gel formulations using
different polymer concentrations (1%, 2% w/w of Carbopol,
and 25%, 30% w/w of PF127) was studied as shown in Figs. 6
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Figure 6 In vitro release proﬁles of MT from gel formulations containing different concentrations of Carbopol. (A) 0.5% (w/w) MT and
(B) 1% (w/w) MT (n= 3, mean ± SD).
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Figure 7 In vitro release proﬁles of MT from gel formulations containing different concentrations of Pluronic F127. (A) 0.5% (w/w) MT
and (B) 1% (w/w) MT(n= 3, mean ± SD).
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Table 3 Kinetic constants (K), diffusional exponents (n) and
correlation coefﬁcients (r2) by linear regression of ln(Mt/M1)
vs ln t. The values are mean ± SD, n= 3.
Formula code n K r2
F1 0.766 ± 0.024 1.057 ± 0.585 0.996
F2 0.504 ± 0.014 5.250 ± 0.078 0.958
F3 0.627 ± 0.135 1.643 ± 0.037 0.990
F4 0.693 ± 0.024 1.398 ± 0.198 0.960
F5 0.868 ± 0.025 0.442 ± 0.051 0.950
F6 0.805 ± 0.043 0.820 ± 0.179 0.990
F7 0.746 ± 0.052 0.434 ± 0.108 0.903
F8 0.959 ± 0.063 0.317 ± 0.117 0.984
Long acting metoprolol tartrate ophthalmic gels 561and 7. In general, the release of MT from the isotonic buffer
solution (pH 6.8) is signiﬁcantly higher than that from the
all formulated gels. The % release of MT from its buffer solu-
tion is 93.2 ± 0.655 after 1 h. The obtained results showed that
the release rate of MT from different gel preparations signiﬁ-
cantly (p< 0.05) decreases as an inverse function of the poly-
mer concentration. Fig. 6 shows the % amounts released of
MT from the different Carbopol gels. It is observed that at
0.5% w/w MT, the amount of drug released after 5 h is
83.05 ± 0.287% and 57.12 ± 0.490% for 1 and 2% w/w Car-
bopol gels, respectively. Moreover, at 1% w/w MT, the% of
the drug released is 90.99 ± 0.381 and 70.47 ± 0.382 for 1%
and 2% w/w Carbopol gels, respectively. The increase in the
viscosity might have contribution to the decreased rate of the
drug release from different gel formulations. This may be
potentiated by the rheology study that proves a direct propor-
tionality between the polymer concentration and the viscosity
value. These ﬁndings are in agreement with the other reported
results (Ricci et al., 2005). In addition, the% amounts of the
drug released using various concentrations of MT (0.5%, 1%
w/w) from PF127 gels (25%, 30% w/w) are represented in
Fig. 7. The obtained data indicated that at 0.5% w/w MT,
the amount of the drug released is 59.4 ± 3.818 and
27.41 ± 1.343% using 25 and 30% w/w PF127, respectively
while at 1% w/w MT, the amount of the drug released is
81.43 ± 3.654 and 72.66 ± 1.624%. For our study the ﬁnding
that higher polymer concentrations resulted in a lower drug re-
lease from the vehicles is in agreement with El-Gendy et al.,
2002, who found that the diffusion coefﬁcient of a solute is in-
versely proportional to the volume fraction occupied by the
gel-forming agent (El-Gendy et al., 2002).
3.4.2. Effect of drug loading on in vitro release
The effect of the initial drug concentration on the MT release
was also evaluated. Figs. 6 and 7 show the release of MT from
various gels using two different concentrations of MT. It is
clear from the results that the release of MT from the gel bases
increases with an increase of the initial load in the vehicles. It
was observed that the% amount released of 0.5 and 1% w/w
MT from 1% w/w Carbopol gels is 83.05 ± 0.287and
90.99 ± 0.381, respectively, and from 2% Carbopol gels it is
57.12 ± 0.460 and 70.47 ± 0.382, respectively (Fig. 6). The
same ﬁnding was observed for the gel formulations containing
Pluronic F127 (Fig. 7). These results indicate that as the con-
centration of the initial drug increases, the release of the drug
also increases (Hassan, 2007).
3.4.3. Kinetic analysis of the release data
The release data of MT from its different gel formulations
were treated mathematically according to krosmeyer equation.
The obtained data are illustrated in Table 3. The values of n
(release exponent) lie between 0.5 and 1.0 for all the formula-
tions exhibiting a non-ﬁckian release behavior controlled by a
combination of diffusion and chain relation mechanism. Our
results are in good agreement with the other reported data
(British Pharmacopeia, 2007).
3.4.4. In vivo performance of MT in rabbit’s eye
In vivo performance of 1% w/w MT on the intra-ocular pres-
sure (IOP) of rabbit’s eye was investigated as a function of the
polymer type (Carbopol 934, Pluronic F127) and the polymerconcentration (1%, 2% of Carbopol and 25%, 30% of
PF127). The beta blocker is known to reduce the IOP when
it is applied topically to the eye thus, the IOP was chosen as
the parameter of the activity (Plummer et al., 2006). Four
parameters were utilized to assess the in vivo activity of the
drug. These parameters are the area above the IOP/ time curve
(AAC), the maximum response (MR), the time of the maxi-
mum response (TMR) and the duration of the drug action
(DA). The results of these parameters are collected and re-
ported in Table 4. The time course of the IOP of rabbit’s eye
following the instillation of 1% MT gels is presented in
Fig. 8. It is clear from Fig. 8 and Table 4 that the duration
of the drug action (DA) using two different Carbopol concen-
trations does not terminate by the end of the experimental
observation period of 5 h. This indicates that, MT formulated
gels have a long duration of the drug action. The difference in
the IOP at the end of the experimental time (5 h) from the ini-
tial values is 5.78, 7.34 mmHg in the case of 1% and 2% Car-
bopol gels, respectively. Through the speciﬁed experimental
time, DA does not show any dependence on the Carbopol con-
centration (p> 0.05). These results could be due to the Carbo-
pol concentrations used. As the concentration of the polymer
increases from 1% to 2% w/w, the viscosity does not signiﬁ-
cantly (p> 0.05) increase. The recorded results of the viscosity
are 10.85 ± 0.219 and 11.0 ± 0.014 (Pas) at the shear rate of
100 s1 for 1% and 2% Carbopol (F2, F4), respectively. With
regard to the area above the IOP/time curve (AAC), Table 4
reﬂects a non dependence (p> 0.05) of the AAC on the con-
centration of Carbopol. The change of the Carbopol concen-
tration from 1% to 2% brings about the same AAC. It is
15.6 and 16.16 mmHg h for 1% and 2% Carbopol gels, respec-
tively. Moreover, the maximum response of the drug (MR) in
the relation to the Carbopol concentration was calculated and
is summarized in table 4. From this table, it is evident that, the
MR is slightly affected by the Carbopol concentration in a way
that, 2-fold increase in Carbopol concentration (from 1% to
2% w/w) brings only about 1.3-fold increase in the MR. In
addition, the difference between the two prepared Carbopol
gels (1% and 2% w/w) is non signiﬁcant (p> 0.05) with re-
gard to the time of the maximum response (TMR) and it gave
the same value (4 h). It was noted that there is no correlation
between the obtained in vitro release rates of MT from the
Carbopol gels and the in vivo pharmacological effect.
On the other hand, Fig. 8 and Table 4 demonstrate that the
duration of the drug action (DA) using the PF127 gels in
the two different concentrations (25% and 30% w/w) persists
Table 4 Values of area above the IOP/time curve, maximum response, time of maximum response and duration of action of 1%
(w/w) metoprolol tartrate of different gel formulations.
Gel formulations (w/w) AAC (mmHg h) Maximum response (mmHg) tmax (h) Duration of action (h)
Carbopol 934
1% 15.60 7.39 4 >5
2% 16.16 9.27 4 >5
Pluronic F127
25% 16.05 5.14 3 5
30% 16.26 3.98 3 5
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Figure 8 Intra-ocular pressure (mm Hg) of rabbits’ eyes after instillation of 1% (w/w) metoprolol tartrate gels. (A) 1% Carbopol gel, (B)
2% Carbopol gel, (C) 25% Pluronic F127 gel and (D) 30% Pluronic F127 ge l (n= 3, mean ± SD).
562 A. E. s. F. Abou el Ela, M.M.E. Khatibonly for the experimental time and reaches the baseline at 5 h.
The differences between the two individual PF127 gels are non
signiﬁcant (p> 0.05) with regard to the duration of the drug
action. From table 4, it is evident that AAC of 1% w/w MT
increases slightly as the concentration of the PF127 increases
and it is 16.05, 16.26 mmHg h for 25 and 30% w/w PF127,
respectively. The statistical analysis of the recorded data for
MR (table 4) depicts that the difference between 25% and
30% w/w PF127 gels is non signiﬁcant (p> 0.05). MR is
5.14, 3.98 mmHg for 25% w/w and 30% w/w PF127 gels,
respectively. The same ﬁnding was obtained by a comparison
between the two individual PF127 gels concerning the time
of the maximum response (TMR). TMR is 3 h for both
PF127 gel formulations. This may be attributed to the non sig-
niﬁcant change in the viscosity of PF127 gels which is
2.19 ± 0.16, 2.75 ± 0.19 (Pas) for 25% and 30% PF127 gels,
respectively as shown in Table 2. From the above mentioned
ﬁndings, it is observed that, the gel formulations of the drug
with the Carbopol polymer produce a greater inﬂuence on
the duration of the drug action as compared to the PF127 gels.Furthermore, there is no correlation between the obtained
in vitro release rates of MT from the Carbopol and Pluronic
F127 gels and the in vivo pharmacological effects. With regard
to the pupil diameter of the eyes of the tested rabbits, it is visu-
ally observed that, at all time points post-instillation of MT
gels, the change in the pupil diameter is non signiﬁcant for
both Carbopol and Pluronic F127 gels as compared to the con-
trol eye (no miotic or medriatic effects).4. Conclusion
The metoprolol tartrate gel formulations were made and
examined under different formulation variables. The nature
of the polymer and its concentration has inﬂuenced the drug
release proﬁles. Higher release rates were observed at lower
polymer concentrations. A direct relationship was noted be-
tween drug concentration and percent of the drug released.
The intra-ocular pressure (IOP) results of rabbits’ eyes treated
with 1% w/w metoprolol tartrate gel formulations showed that
Long acting metoprolol tartrate ophthalmic gels 563Carbopol 934 polymer which had higher viscosity values, ex-
tended the duration of the pressure-reducing effect of MT to
more than 5 h. These results may be due to the prolongation
of the ocular contact time, and assistance in drug penetration
into the ocular tissue, which increases the duration of the ac-
tion of the drug and its bioavailability.
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